Urinary excretion of 11-nor-9-carboxy-Δ9- tetrahydrocannabinol in a pregnant woman following heavy, chronic cannabis use

Journal of Analytical Toxicology

Volumn 33, Issue 9, 2009, Pages 610-614

  Westin, Andreas A ^a   Huestis, Marilyn A ^b   Aarstad, Kjell ^a   Spigset, Olav ^a,c  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^c NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABIS; TETRAHYDROCANNABINOLIC ACID; 11 NOR DELTA(9) TETRAHYDROCANNABINOL 9 CARBOXYLIC ACID; 11-NOR-DELTA(9)-TETRAHYDROCANNABINOL-9-CARBOXYLIC ACID; DRUG DERIVATIVE; TETRAHYDROCANNABINOL;

ADULT; ARTICLE; CANNABIS ADDICTION; CANNABIS SMOKING; FEMALE; HUMAN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PREGNANT WOMAN; URINALYSIS; URINARY EXCRETION; URINE LEVEL; ALGORITHM; CASE REPORT; HALF LIFE TIME; METABOLIC CLEARANCE RATE; PREDICTION AND FORECASTING; PREGNANCY; REPRODUCIBILITY; SUBSTANCE ABUSE; URINE;

CANNABIS;

ALGORITHMS; CHROMATOGRAPHY, LIQUID; FEMALE; HALF-LIFE; HUMANS; MARIJUANA ABUSE; MARIJUANA SMOKING; MASS SPECTROMETRY; METABOLIC CLEARANCE RATE; PREDICTIVE VALUE OF TESTS; PREGNANCY; REPRODUCIBILITY OF RESULTS; SUBSTANCE ABUSE DETECTION; TETRAHYDROCANNABINOL; YOUNG ADULT;

EID: 74549156316     PISSN: 01464760     EISSN: 01464760     Source Type: Journal    
DOI: 10.1093/jat/33.9.610     Document Type: Article

References (23)

1. R. Lennestål, H.A. Lakso, M. Nilsson, and T. Mjörndal. Urine monitoring of diazepam abuse - new intake or not? J. Anal. Toxicol. 32: 402-407 (2008).
2. J.E. Manno, K.E. Ferslew, and B.R. Manno. Urine excretion patterns of cannabinoids and the clinical application of the EMIT-d.a.u. cannabinoid urine assay for substance abuse treatment. In The Cannabinoids: Chemical, Pharmacologic, and Therapeutic Aspects, S. Agurell, W.L. Dewey, and R.E. Willette, Eds. Harcourt Brace Jonanovich, Orlando, FL, 1984, pp 281-290.
3. M.A. Huestis and E.J. Cone. Differentiating new marijuana use from residual drug excretion in occasional marijuana users. J. Anal. Toxicol. 22: 445-454 (1998).
4. F. Grotenhermen. Pharmacokinetics and pharmacodynamics of cannabinoids. Clin. Pharmacokinet. 42: 327-360 (2003).
5. M.A. Huestis, J.M. Mitchell, and E.J. Cone. Lowering the federally mandated cannabinoid immunoassay cutoff increases true-positive results. Clin. Chem. 40: 729-733 (1994).
6. 9-tetrahydrocannabinol, cannabidiol and cannabinol. Handb. Exp. Pharmacol. 168: 657-690 (2005).
7. 9- tetrahydrocannnabinol in cannabis users during continuously monitored abstinence. J. Anal. Toxicol. 32: 562-569 (2008).
8. E. Johansson and M.M. Halldin. Urinary excretion half-life of delta 1-tetrahydrocannabinol-7-oic acid in heavy marijuana users after smoking. J. Anal. Toxicol. 13: 218-223 (1989).
9. C.A. Dackis, A.L. Pottash, W. Annitto, and M.S. Gold. Persistence of urinary marijuana levels after supervised abstinence. Am. J. Psychiatry 139: 1196-1198 (1982).
10. G.M. Ellis, Jr., M.A. Mann, B.A. Judson, N.T. Schramm, and A. Tashchian. Excretion patterns of cannabinoid metabolites after last use in a group of chronic users. Clin. Pharmacol. Ther. 38: 572-578 (1985).
11. P. Lafolie, O. Beck, G. Blennow, L. Boreus, S. Borg, C.E. Elwin, L. Karlsson, G. Odelius, and P. Hjemdahl. Importance of creatinine analyses of urine when screening for abused drugs. Clin. Chem. 37: 1927-1931 (1991).
12. 9-tetrahydrocannabinol: a case with an apparent long terminal half-life. Scand. J. Clin. Lab Invest. 66: 169-171 (2006).
13. K.B. Kielland. Urinary excretion of cannabis metabolites. Tidsskr Nor Laegeforen. 112: 1585-1586 (1992) (in Norwegian).
14. Norwegian ministry of health and care services: Act on social services, § 6-2a, 1991.
15. Norwegian ministry of health and care services: Act on health personell, § 32, 2001.
16. M.L. Smith, A.J. Barnes, and M.A. Huestis. Identifying new cannabis use with urine creatinine-normalized THCCOOH concentrations and time intervals between specimen collections. J. Anal. Toxicol. 33: 185-189 (2009).
17. A.D. Fraser and D. Worth. Monitoring urinary excretion of cannabinoids by fluorescence-polarization immunoassay: a cannabinoid-to-creatinine ratio study. Ther. Drug Monit. 24: 746-750 (2002).
18. 9-THC-COOH to creatinine ratio study. Forensic Sci. Int. 137: 196-202 (2003).
19. 9-THC-COOH to creatinine ratio study #2. Forensic Sci. Int. 133: 26-31 (2003).
20. 9-THC: cannabinoid metabolites to creatinine ratio study IV. Forensic Sci. Int. 143: 147-152 (2004).
21. G.D. Anderson. Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach. Clin. Pharmacokinet. 44: 989-1008 (2005).
22. P.M. Catalano. Management of obesity in pregnancy. Obstet. Gynecol. 109: 419-433 (2007).
23. E.R. Garrett and C.A. Hunt. Physiochemical properties, solubility, and protein binding of delta9-tetrahydrocannabinol. J. Pharm. Sci. 63: 1056-1064 (1974).